Evidence map›Paper›PMID 35338335›Full record

ArticleThe ISME journal2022

Pseudomonas aeruginosa polysaccharide Psl supports airway microbial community development.

Sara N Stoner, Joshua J Baty, Jessica A Scoffield

Open access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. BioMed research international · 2026
    Review
  5. Activation of theInfection and immunity · 2025
    Article
  6. Article
  7. Article
  8. Biofilm Formation ofMicroorganisms · 2025
    Review
  9. Dpr-mediated HJournal of bacteriology · 2024
    Article
  10. Article
  11. Cytotoxic rhamnolipid micelles drive acute virulence inbioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Photodynamic Activity of Chlorophyllin and Polyethylenimine onInternational journal of molecular sciences · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Frontiers in cellular and infection microbiology · 2023
    Review
  18. Commensal colonization reducesFrontiers in cellular and infection microbiology · 2023
    Article
  19. Rapid Synergistic Biofilm Production ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sara N StonerDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Joshua J BatyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Jessica A ScoffieldDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. jscoff@uab.edu.ORCID http://orcid.org/0000-0003-3495-848X
University of Alabama at Birmingham · US

Funding

UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
Dental Academic Research Training Program (DART)T90DE022736 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Amjad Javed · 2012 to 2026
$6.7M
Elucidating the role of reactive nitrogen species in bacterial interactionsR35GM142748 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCOFFIELD, JESSICA A · 2021 to 2025
$1.9M
UAB Predoctoral Training Program in Lung DiseasesT32HL134640 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SWORDS, WILLIAM E · 2017 to 2021
$1.0M
Inhibition of Streptococcus mutans by oral commensal streptococci and nitrie-mediated activityR00DE025913 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCOFFIELD, JESSICA A · 2018 to 2020
$749k
Interactions between Pseudomonas aeruginosa and Streptococcus salivarius and effects on the host immune responseF31HL162487 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STONER, SARA N · 2022 to 2023
$57k
NCATS NIH HHS UL1 TR001417NHLBI NIH HHS F31 HL162487NHLBI NIH HHS T32 HL134640NIDCR NIH HHS R00 DE025913NIDCR NIH HHS T90 DE022736NIDDK NIH HHS P30 DK072482NIGMS NIH HHS R35 GM142748
6 · The paper itself

Abstract

Pseudomonas aeruginosa dominates the complex polymicrobial cystic fibrosis (CF) airway and is a leading cause of death in persons with CF. Oral streptococcal colonization has been associated with stable CF lung function. However, no studies have demonstrated how Streptococcus salivarius, the most abundant streptococcal species found in individuals with stable CF lung disease, potentially improves lung function or becomes incorporated into the CF airway biofilm. By utilizing a two-species biofilm model to probe interactions between S. salivarius and P. aeruginosa, we discovered that the P. aeruginosa exopolysaccharide Psl promoted S. salivarius biofilm formation. Further, we identified a S. salivarius maltose-binding protein (MalE) that is required for promotion of biofilm formation both in vitro and in a Drosophila melanogaster co-infection model. Finally, we demonstrate that promotion of dual biofilm formation with S. salivarius is common among environmental and clinical P. aeruginosa isolates. Overall, our data supports a model in which S. salivarius uses a sugar-binding protein to interact with P. aeruginosa exopolysaccharide, which may be a strategy by which S. salivarius establishes itself within the CF airway microbial community.

Indexed as

Cystic FibrosisMicrobiotaPseudomonas InfectionsAnimalsBiofilmsDrosophila melanogasterPolysaccharidesPseudomonas aeruginosaPolysaccharides

Identifiers

PMID35338335
PMCPMC9213427
OpenAlexW4220974927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.